Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Recruiting now · Has a placebo group

Conditions studied: Systemic Lupus Erythematosus

In brief

PRIMULA Preg (Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users) is a prospective, observational cohort study designed to evaluate the association between anifrolumab exposure during pregnancy and subsequent adverse maternal, fetal, and infant outcomes. This study will fulfil an FDA post-marketing requirement.

Key facts

Study ID
NCT06659029
Run by
AstraZeneca
People needed
442
Starts
2025-07-01
Expected to finish
2031-04-15
Last updated by the study team
2026-06-24

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.